13 . 03 .2024
Press release
Galderma launches IPO on the SIX Swiss Exchange and sets price range
13 . 03 .2024
News story
Dr. Flor A. Mayoral: A story of creativity, passion and dermatological innovation with Galderma
10 . 03 .2024
Press release
Galderma @ AAD 2024: new data demonstrate the long-term efficacy of nemolizumab in prurigo nodularis and its durability in atopic dermatitis
29 . 02 .2024
Press release
Galderma announces record 2023 net sales of over 4 B USD and significant core EBITDA margin expansion
28 . 02 .2024
Press release
Galderma to showcase latest updates from its broad, innovative and leading dermatology portfolio at the 2024 American Academy of Dermatology annual meeting
14 . 02 .2024
Press release
Galderma announces regulatory filing acceptance for nemolizumab in prurigo nodularis and atopic dermatitis in the U.S. and EU
